Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Aimin HUI
Aimin HUI
Positions:

Executive President of Fosun Pharma

Company:

Fosun Pharma

Dr. Aimin Hui is the Executive President of Fosun Pharma, President of Global R&D, and Chief Medical Officer. He is currently the Director of Shanghai Key Laboratory of Stem Cell Therapy and the Deputy Director of the Oncology Committee of China Pharmaceutical Association. He was the Vice President of Global Clinical R&D of Sanofi and the Vice Chairman of the Academic Committee of the 5th China Academic Oncology Conference. He has led the global development, registration and marketing of several small molecule and biologic anti-cancer drugs such as Izaxomib and Isatuximab. He has led the development and registration of several innovative drugs such as Ixazomib and Avatrombopag in China. He has published more than 80 papers in New England Journal of Medicine, Nature Medicine, Lancet, Cell Cancer, etc. Recently, he led the collaboration between Fosun and BioNTech on the development and registration of mRNA vaccines in Greater China (already marketed in Hong Kong and Macau).